BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12189064)

  • 1. Exploiting subjects in placebo-controlled trials.
    Jecker NS
    Am J Bioeth; 2002; 2(2):19-20. PubMed ID: 12189064
    [No Abstract]   [Full Text] [Related]  

  • 2. Subject indifference and the justification of placebo-controlled trials.
    Veatch RM
    Am J Bioeth; 2002; 2(2):12-3. PubMed ID: 12189061
    [No Abstract]   [Full Text] [Related]  

  • 3. Adolescents as doubly-vulnerable research subjects.
    Kopelman LM
    Am J Bioeth; 2004; 4(1):50-2. PubMed ID: 15035950
    [No Abstract]   [Full Text] [Related]  

  • 4. Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception.
    Appelbaum PS
    Am J Bioeth; 2002; 2(2):22-3. PubMed ID: 12189066
    [No Abstract]   [Full Text] [Related]  

  • 5. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice.
    Lemmens T; Miller PB
    Am J Bioeth; 2002; 2(2):14-7. PubMed ID: 12189062
    [No Abstract]   [Full Text] [Related]  

  • 6. What makes placebo-controlled trials unethical?
    Miller FG; Brody H
    Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic beneficence and placebo controls.
    Ackerman TF
    Am J Bioeth; 2002; 2(2):21-2. PubMed ID: 12189065
    [No Abstract]   [Full Text] [Related]  

  • 8. A closer look at the bad deal trial: beyond clinical equipoise.
    Jansen LA
    Hastings Cent Rep; 2005; 35(5):29-36. PubMed ID: 16295262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to conduct a placebo-controlled trial may be unethical.
    Cohen PJ
    Am J Bioeth; 2002; 2(2):24. PubMed ID: 12189067
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo controls: scientific and ethical issues.
    Kowalski CJ
    Am J Bioeth; 2002; 2(2):33-4. PubMed ID: 12189073
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethics of single blind trials.
    Heckerling PS
    IRB; 2005; 27(4):12-6. PubMed ID: 16220629
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trials in vulnerable populations.
    Cook D; Moore-Cox A; Xavier D; Lauzier F; Roberts I
    Clin Trials; 2008; 5(1):61-9. PubMed ID: 18283082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics and science of placebo-controlled trials: assay sensitivity and the Duhem-Quine thesis.
    Anderson JA
    J Med Philos; 2006 Feb; 31(1):65-81. PubMed ID: 16464770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulnerable subjects and civic professionalism: would six-sigma research and research ethics consultation solve the vulnerability problem?
    Marshall MF
    Am J Bioeth; 2004; 4(3):54-5; discussion W32. PubMed ID: 16192141
    [No Abstract]   [Full Text] [Related]  

  • 15. A modest proposal.
    Burris S; Davis C
    Am J Bioeth; 2009 Nov; 9(11):W3-4. PubMed ID: 19882443
    [No Abstract]   [Full Text] [Related]  

  • 16. Is informed consent enough? Monetary incentives for research participation and the integrity of biomedicine.
    Kuczewski M
    Am J Bioeth; 2001; 1(2):49-51. PubMed ID: 11951891
    [No Abstract]   [Full Text] [Related]  

  • 17. Are concerns about the ethics of placebos a stalking horse for other issues?
    Healy D
    Am J Bioeth; 2002; 2(2):17-9. PubMed ID: 12189063
    [No Abstract]   [Full Text] [Related]  

  • 18. Coercion and the SATURN study.
    Resnik DB
    Am J Bioeth; 2004; 4(1):38-40. PubMed ID: 15035945
    [No Abstract]   [Full Text] [Related]  

  • 19. Unproven or unsatisfactory versus equipoise in emergency research with waived consent.
    Spellecy R
    Am J Bioeth; 2006; 6(3):44-5. PubMed ID: 16754452
    [No Abstract]   [Full Text] [Related]  

  • 20. Deflating rhetoric about "ethical inflation".
    Rennie S; Rosenfeld LB
    Am J Bioeth; 2009 Nov; 9(11):58-60. PubMed ID: 19882463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.